CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Twitter Chat: Melanoma and Immunotherapy

    Join the #ImmunoChat conversation on May 19 at 4:00 p.m. ET.

    May 18, 2015| Emily Helck
  • CRI’s Insights for ASCO 2015

    Our expert panel in cancer immunotherapy weighs in on what to look for at this year's meeting.

    May 18, 2015| Jill O'Donnell-Tormey, PhD
  • 2015 International Meeting: Translating Science Into Survival

    Hosted by CRI, CIMT, EATI, and AACR, the Inaugural International Cancer Immunotherapy Conference (CICON) 2015 will bring…

    May 11, 2015| Michelle Liew
  • Watching AACR from Near and Far

    Social media added a new dimension to the conversation at AACR.

    April 24, 2015| Emily Helck
  • AACR 2015: Report from Day 5

    Some lesser-known cell types in the immune response to cancer were discussed on the meeting's final day.

    April 22, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 4

    Spotlight on CAR T cell therapy.

    April 21, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 3

    Results of two high-profile clinical trials, among others, are covered on the meeting's third day.

    April 20, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 2

    Our report on the latest developments in cancer immunotherapy from day 2 at the annual AACR meeting…

    April 19, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 1

    Presentations from the annual meeting of the American Association for Cancer Research span many cancer immunotherapy topics.

    April 19, 2015| Matthew Tontonoz
Previous Page
1 … 80 81 82 83 84 … 91
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute